Carol Karp
General Counsel at PROTHENA CORPORATION PLC
Net worth: - $ as of 2024-03-30
Profile
Carol D.
Karp is currently the Vice Chairman-Trustees Board at Rochester Christian University and the Chief Regulatory Officer at Prothena Corp.
Plc.
Previously, she held positions such as Officer at VIVUS, Inc., SVP-Regulatory Affairs, Quality & Drug Safety at CV Therapeutics, Inc., Senior VP-Regulatory Affairs & Compliance at Esperion Therapeutics, Inc., Vice President-Scientific Affairs at Powderject Technologies BV, and Vice President & Head-Global Regulatory Affairs at Janssen Alzheimer Immunotherapy.
Ms. Karp obtained her undergraduate degree from Rochester Christian University and New York University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
PROTHENA CORP. PLC
-.--% | 2024-03-03 | 0 ( -.--% ) | - $ | 2024-03-30 |
Carol Karp active positions
| Companies | Position | Start |
|---|---|---|
| PROTHENA CORPORATION PLC | General Counsel | 2016-12-14 |
| Rochester Christian University | Director/Board Member | - |
Former positions of Carol Karp
| Companies | Position | End |
|---|---|---|
| ESPERION THERAPEUTICS, INC. | Compliance Officer | 2013-12-31 |
| Janssen Alzheimer Immunotherapy | General Counsel | 2012-12-31 |
CV Therapeutics, Inc.
 CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | General Counsel | 2011-05-01 |
| VIVUS, INC. | Corporate Officer/Principal | - |
| Powderject Technologies BV | Chief Tech/Sci/R&D Officer | - |
Training of Carol Karp
| Rochester Christian University | Undergraduate Degree |
| New York University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| ESPERION THERAPEUTICS, INC. | Health Technology |
| PROTHENA CORPORATION PLC | Health Technology |
| Private companies | 4 |
|---|---|
VIVUS, Inc.
 VIVUS, Inc. Pharmaceuticals: MajorHealth Technology VIVUS, Inc. engaged in the development and commercialization of novel therapeutic products. The firm’s products were indicated for the treatment of obese and overweight patients, exocrine pancreatic insufficiency, and erectile dysfunction. Its products include PANCREAZE, Qsymia, and STENDRA/SPEDRA. The company was founded by Virgil A. Place in April 16, 1991 and it was headquartered in Campbell, CA. | Health Technology |
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Health Technology |
| Powderject Technologies BV | |
| Janssen Alzheimer Immunotherapy |
- Stock Market
- Insiders
- Carol Karp
